Making good on a threat, Ohio Attorney General Dave Yost filed a lawsuit against OptumRx, the pharmacy benefits manager, for allegedly overcharging $16 million to a state agency for generic drugs.

Specifically, Yost contended that OptumRx, which is owned by UnitedHealth Group (UNH), the big insurer, failed to pass along discounts for medicines that were purchased by the Ohio Bureau of Workers’ Compensation between 2015 and 2018. He first raised the allegation in a Feb. 11 letter to the PBM in which the overcharges are a “matter of considerable public significance.”

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

Your daily dose of news in health and medicine

Privacy Policy